About Starsource Multitrade Limited
Data last updated: 24 February 2026
Starsource Multitrade Limited is a public limited company based in Kalyan, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 August 1942, the company has been in operation for over 84 years.
Registered with ROC Mumbai under CIN U99999MH1942PTC003556. Listed on BSE: 506365.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹1.5 Cr. Formerly known as Chemo Pharma Laboratories Ltd. It is led by directors including Ruchit Mehta and Sarvagya Goel.
Last AGM: 24 September 2025. Financial statements filed for year ended 31 March 2025. Office: 5 Kumud Apartment Chs Limited Karnik Road Chikan Ghar Kalyan, Maharashtra, India – 421301.
As per the financials filed for FY 2025, the company reported a revenue of ₹61.98 Lakh, a decline of 66% compared to the previous year.
The company is associated with 1 brand - The Chemo Pharma Laboratories. As per MCA filings, the company has open charges of ₹50,000 and satisfied charges of ₹6.24 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website thechemopharmalaboratoriesltd.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address5 Kumud Apartment Chs Limited Karnik Road Chikan Ghar Kalyan, Maharashtra, India – 421301
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Starsource Multitrade Limited
Starsource Multitrade Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L46900MH1942PLC003556, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L46900MH1942PLC003556 | Current |
| U99999MH1942PTC003556 | Previous |
| L99999MH1942PLC003556 | Previous |
Associated Brands with Starsource Multitrade Limited
Starsource Multitrade Limited operates one associated brand: The Chemo Pharma Laboratories. These brands represent Starsource Multitrade Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Bulk drugs and pharmaceuticals have been developed since 1942. | thechemopharmalaboratoriesltd.com |
Competitors & Alternatives of Starsource Multitrade Limited
Brands and companies operating in the same space as Starsource Multitrade Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Business Activity of Starsource Multitrade Limited
Starsource Multitrade Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Starsource Multitrade Limited
Starsource Multitrade Limited is audited by S S R V & Associates (ICAI peer reviewed, certificate valid till 2027-06-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| S S R V & Associates (ICAI peer reviewed, certificate valid till 2027-06-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Starsource Multitrade Limited
Starsource Multitrade Limited is currently managed by 6 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Ruchit Mehta
Also directs:
11Th Boulevard Films Llp, Alphatone Multitrade Limited, Sej Real Estate Private Limited and 3 more
|
Director | 01 Apr 2025 | 1 Years 3 Months | Current |
|
Sarvagya Goel
Also directs:
Grand Oak Canyons Distillery Limited
|
Director | 01 Apr 2025 | 1 Years 3 Months | Current |
| Shilpy Chopra | Director | 01 Apr 2025 | 1 Years 3 Months | Current |
| Utsav Trivedi | Director | 01 Apr 2025 | 1 Years 3 Months | Current |
| Simiran Ankleshwar Tripathi | Director | 31 Dec 2024 | 1 Years 6 Months | Current |
Financials of Starsource Multitrade Limited FY 2026 filings available
Starsource Multitrade Limited reported revenue of ₹52.57 Lakh (up ) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹52.57 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Income | ₹2.39 Lakh | ₹61.98 Lakh | ₹1.84 Cr | ₹29.51 Lakh | ₹78.89 Lakh | ₹66.8 Lakh | ₹99.67 Lakh | ₹82.25 Lakh |
| Total Income | ₹54.96 Lakh | ₹61.98 Lakh | ₹1.84 Cr | ₹29.51 Lakh | ₹78.89 Lakh | ₹66.8 Lakh | ₹99.67 Lakh | ₹82.25 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹37.65 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹8.89 Lakh | ₹2.16 Lakh | ₹1.85 Lakh | ₹7.91 Lakh | ₹17.31 Lakh | ₹12.62 Lakh | ₹18.13 Lakh | ₹22.18 Lakh |
| Finance Costs | ₹10,000 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2.31 Lakh | ₹0 |
| Depreciation & Amortisation | ₹3,000 | ₹54,000 | ₹83,000 | ₹1.31 Lakh | ₹1.89 Lakh | ₹2.39 Lakh | ₹0 | ₹47,000 |
| Other Expenses | ₹11.94 Cr | ₹9.47 Lakh | ₹16.78 Lakh | ₹12.97 Lakh | ₹23.2 Lakh | ₹20.71 Lakh | ₹29.82 Lakh | ₹34.14 Lakh |
| Total Expenses | ₹12.4 Cr | ₹12.17 Lakh | ₹19.46 Lakh | ₹22.19 Lakh | ₹42.4 Lakh | ₹35.72 Lakh | ₹50.26 Lakh | ₹56.79 Lakh |
| Profit Before Exceptional Items & Tax | -₹11.85 Cr | ₹49.81 Lakh | ₹1.64 Cr | ₹7.32 Lakh | ₹36.49 Lakh | ₹31.08 Lakh | ₹49.41 Lakh | ₹25.46 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹11.85 Cr | ₹49.81 Lakh | ₹1.64 Cr | ₹7.32 Lakh | ₹36.49 Lakh | ₹31.08 Lakh | ₹49.41 Lakh | ₹25.46 Lakh |
| Total Tax Expense | ₹1,000 | ₹15.58 Lakh | ₹33.54 Lakh | -₹9.49 Lakh | ₹6.31 Lakh | ₹6.07 Lakh | ₹7.9 Lakh | ₹4.83 Lakh |
| Net Profit | -₹11.85 Cr | ₹34.23 Lakh | ₹1.2 Cr | ₹4.74 Lakh | ₹55.99 Lakh | ₹25.01 Lakh | ₹41.51 Lakh | ₹20.63 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹11.85 Cr | ₹34.23 Lakh | ₹1.2 Cr | ₹4.74 Lakh | ₹55.99 Lakh | ₹25.01 Lakh | ₹41.51 Lakh | ₹20.63 Lakh |
| EBITDA (computed) | -₹11.85 Cr | ₹50.35 Lakh | ₹1.65 Cr | ₹8.63 Lakh | ₹38.38 Lakh | ₹33.47 Lakh | ₹51.72 Lakh | ₹25.93 Lakh |
| Basic EPS | ₹-79.03 | ₹2.28 | ₹0.00 | ₹0.32 | ₹3.73 | ₹0.00 | ₹2.77 | ₹1.38 |
| Diluted EPS | ₹-79.03 | ₹2.28 | ₹0.00 | ₹0.32 | ₹3.73 | ₹0.00 | ₹2.77 | ₹1.38 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1.81 Cr | ₹13.35 Cr | ₹13.02 Cr | ₹11.62 Cr | ₹11.66 Cr | ₹11.05 Cr | ₹10.97 Cr | ₹10.42 Cr |
| Non-current Assets | ₹71,000 | ₹2.54 Cr | ₹6.76 Cr | ₹5.49 Cr | ₹5.37 Cr | ₹9.29 Lakh | ₹2.06 Cr | ₹1.88 Cr |
| Current Assets | ₹1.8 Cr | ₹10.81 Cr | ₹6.25 Cr | ₹6.13 Cr | ₹6.3 Cr | ₹10.96 Cr | ₹8.91 Cr | ₹8.54 Cr |
| Property, Plant & Equipment | ₹10,000 | ₹1.23 Lakh | ₹1.78 Lakh | ₹2.6 Lakh | ₹3.91 Lakh | ₹5.22 Lakh | ₹7.47 Lakh | ₹30,000 |
| Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Trade Receivables | ₹48.84 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Cash & Equivalents | ₹1.22 Lakh | ₹0 | ₹60.58 Lakh | ₹55.59 Lakh | ₹68.59 Lakh | ₹0 | ₹80.84 Lakh | ₹46.62 Lakh |
| Equity (Net Worth) | ₹1.29 Cr | ₹13.14 Cr | ₹12.8 Cr | ₹11.6 Cr | ₹11.55 Cr | ₹10.99 Cr | ₹10.74 Cr | ₹10.33 Cr |
| Equity Share Capital | ₹1.5 Cr | ₹1.5 Cr | ₹1.5 Cr | ₹1.5 Cr | ₹1.5 Cr | ₹1.5 Cr | ₹1.5 Cr | ₹1.5 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹51.58 Lakh | ₹20.52 Lakh | ₹17.81 Lakh | ₹2 Lakh | ₹10.83 Lakh | ₹5.84 Lakh | ₹22.1 Lakh | ₹9.14 Lakh |
| Total Liabilities | ₹52.21 Lakh | ₹20.52 Lakh | ₹21.28 Lakh | ₹2 Lakh | ₹10.83 Lakh | ₹5.84 Lakh | ₹22.1 Lakh | ₹9.14 Lakh |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹10.62 Cr | -₹28.24 Lakh | ₹89.02 Lakh | -₹67.38 Lakh | ₹2.87 Cr |
| Investing Cash Flow | ₹1.09 Lakh | ₹10.46 Cr | -₹69.13 Lakh | ₹62.01 Lakh | -₹2.23 Cr |
| Financing Cash Flow | ₹0 | -₹15.86 Lakh | -₹14.9 Lakh | -₹7.63 Lakh | -₹2.12 Cr |
| Capital Expenditure | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | -₹10.62 Cr | -₹28.24 Lakh | ₹89.02 Lakh | -₹67.38 Lakh | ₹2.87 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹10.61 Cr | ₹10.02 Cr | ₹4.99 Lakh | -₹13 Lakh | -₹1.49 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹0 | ₹0 | ₹52.57 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Income | ₹9,000 | ₹0 | ₹0 | ₹2.07 Lakh | -₹16.41 Lakh | -₹14.88 Lakh | ₹63.1 Lakh | ₹30.18 Lakh |
| Total Income | ₹9,000 | ₹0 | ₹52.57 Lakh | ₹2.07 Lakh | -₹16.41 Lakh | -₹14.88 Lakh | ₹63.1 Lakh | ₹30.18 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹37.65 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹2.16 Lakh | ₹2.16 Lakh | ₹2.16 Lakh | ₹2.41 Lakh | ₹54,000 | ₹54,000 | ₹54,000 | ₹54,000 |
| Finance Costs | ₹0 | ₹0 | ₹1,000 | ₹5,000 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹3,000 | ₹0 | ₹0 | ₹0 | ₹14,000 | ₹14,000 | ₹14,000 | ₹14,000 |
| Other Expenses | ₹5.02 Lakh | ₹6.49 Lakh | ₹2.95 Lakh | ₹11.8 Cr | ₹1.29 Lakh | ₹1.92 Lakh | ₹1.42 Lakh | ₹4.84 Lakh |
| Total Expenses | ₹7.21 Lakh | ₹8.65 Lakh | ₹42.77 Lakh | ₹11.83 Cr | ₹1.97 Lakh | ₹2.6 Lakh | ₹2.1 Lakh | ₹5.52 Lakh |
| Profit Before Exceptional Items & Tax | -₹7.12 Lakh | -₹8.65 Lakh | ₹9.8 Lakh | -₹11.81 Cr | -₹18.38 Lakh | -₹17.48 Lakh | ₹61 Lakh | ₹24.66 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹7.12 Lakh | -₹8.65 Lakh | ₹9.8 Lakh | -₹11.81 Cr | -₹18.38 Lakh | -₹17.48 Lakh | ₹61 Lakh | ₹24.66 Lakh |
| Total Tax Expense | ₹1,000 | ₹0 | ₹0 | ₹0 | ₹15.58 Lakh | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹7.13 Lakh | -₹8.65 Lakh | ₹9.8 Lakh | -₹11.81 Cr | -₹33.96 Lakh | -₹17.48 Lakh | ₹61 Lakh | ₹24.66 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹7.13 Lakh | -₹8.65 Lakh | ₹9.8 Lakh | -₹11.81 Cr | -₹33.96 Lakh | -₹17.48 Lakh | ₹61 Lakh | ₹24.66 Lakh |
| EBITDA (computed) | -₹7.09 Lakh | -₹8.65 Lakh | ₹9.81 Lakh | -₹11.8 Cr | -₹18.24 Lakh | -₹17.34 Lakh | ₹61.14 Lakh | ₹24.8 Lakh |
| Basic EPS | ₹-0.48 | ₹-0.58 | ₹0.65 | ₹-78.70 | ₹-2.26 | ₹-1.17 | ₹4.07 | ₹0.00 |
| Diluted EPS | ₹-0.48 | ₹-0.58 | ₹0.65 | ₹-78.70 | ₹-2.26 | ₹-1.17 | ₹4.07 | ₹0.00 |
Charges & Borrowings of Starsource Multitrade Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 1990 | Bank of Baroda | ₹4.25 Cr | Satisfied |
| 01 Dec 1988 | Bank of Baroda . | ₹14.24 Lakh | Satisfied |
| 24 Feb 1988 | Bank of Baroda | ₹20 Lakh | Satisfied |
| 20 Jun 1987 | Bank of Baroda . | ₹8.6 Lakh | Satisfied |
| 28 Jun 1983 | Bank of Baroda | ₹50 Lakh | Satisfied |
Total charge records: 20 View all charges
Employees and EPFO Compliance at Starsource Multitrade Limited
View historical data on people associated with Starsource Multitrade Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Starsource Multitrade Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Starsource Multitrade Limited
GSTIN & GST Filing Data of Starsource Multitrade Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Starsource Multitrade Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Starsource Multitrade Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Starsource Multitrade Limited
MSME Payment Delays by Starsource Multitrade Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Starsource Multitrade Limited
Subsidiaries & Group Companies of Starsource Multitrade Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Starsource Multitrade Limited with ownership details.
MCA Filings & Documents of Starsource Multitrade Limited
MCA Filings & Documents of Starsource Multitrade Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Starsource Multitrade Limited
Recent News on Starsource Multitrade Limited
Frequently Asked Questions about Starsource Multitrade Limited
Starsource Multitrade Limited is an active public limited company in the pharma sector based in Kalyan, Maharashtra, India. It was incorporated on 17 August 1942 (84+ years old) and is registered under CIN L46900MH1942PLC003556. Listed on BSE: 506365.
Starsource Multitrade Limited reported revenue of ₹61.98 Lakh for FY 2025 (down 66.00% YoY).
The current directors of Starsource Multitrade Limited are:
The primary industry of Starsource Multitrade Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Starsource Multitrade Limited is listed on BSE with code 506365.
Starsource Multitrade Limited can be reached at the registered office: 5 Kumud Apartment Chs Limited Karnik Road Chikan Ghar Kalyan, Maharashtra, India – 421301, or through the website thechemopharmalaboratoriesltd.com.